Synthesis, Structural Elucidation and Pharmacological Applications of Cu(II) Heteroleptic Carboxylates
Authors:
- Shaker UllahSUShaker Ullah
- Muhammad SirajuddinMSMuhammad Sirajuddin
- Zafran UllahZUZafran Ullah
- Afifa MushtaqAMAfifa Mushtaq
- Saba NazSNSaba Naz
- Muhammad ZubairMZMuhammad Zubair
- Ali HaiderAHAli Haider
- Saqib AliSASaqib Ali
- Maciej KubickiMKMaciej Kubicki
- Tanveer A. WaniTWTanveer A. Wani
- Seema ZargarSZSeema Zargar
- Mehboob Ur RehmanMRMehboob Ur Rehman
Open Access
- 3 May 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (5) , 693
Abstract
Six heteroleptic Cu(II) carboxylates (1–6) were prepared by reacting 2-chlorophenyl acetic acid (L1), 3-chlorophenyl acetic acid (L2), and substituted pyridine (2-cyanopyridine and 2-chlorocyanopyridine). The solid-state behavior of the complexes was described via vibrational spectroscopy (FT-IR), which revealed that the carboxylate moieties adopted different coordination modes around the Cu(II) center. A paddlewheel dinuclear structure with distorted square pyramidal geometry was elucidated from the crystal data for complexes 2 and 5 with substituted pyridine moieties at the axial positions. The presence of irreversible metal-centered oxidation reduction peaks confirms the electroactive nature of the complexes. A relatively higher binding affinity was observed for the interaction of SS-DNA with complexes 2–6 compared to L1 and L2. The findings of the DNA interaction study indicate an intercalative mode of interaction. The maximum inhibition against acetylcholinesterase enzyme was caused for complex 2 (IC50 = 2 µg/mL) compared to the standard drug Glutamine (IC50 = 2.10 µg/mL) while the maximum inhibition was found for butyrylcholinesterase enzyme by complex 4 (IC50 = 3 µg/mL) compared to the standard drug Glutamine (IC50 = 3.40 µg/mL). The findings of the enzymatic activity suggest that the under study compounds have potential for curing of Alzheimer’s disease. Similarly, complexes 2 and 4 possess the maximum inhibition as revealed from the free radical scavenging activity performed against DPPH and H2O2.Keywords
Funding Information
- King Saud University (RSP2023R357)
This publication has 56 references indexed in Scilit:
- Synthesis, characterization and X-ray structural studies of four copper (II) complexes containing dinuclear paddle wheel structuresBMC Chemistry, 2013
- Carboxylic Acid (Bio)Isosteres in Drug DesignChemMedChem, 2013
- Influence of the nature of organic components in dinuclear copper(II) pivalates on the composition of thermal decomposition productsPolyhedron, 2010
- The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from PortugalJournal of Ethnopharmacology, 2006
- Bactericidal activity of different oxovanadium(IV) complexes with Schiff bases and application of chelation theoryJournal of Enzyme Inhibition and Medicinal Chemistry, 2006
- Galanthamine from snowdrop—the development of a modern drug against Alzheimer’s disease from local Caucasian knowledgeJournal of Ethnopharmacology, 2004
- Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plantsJournal of Ethnopharmacology, 2004
- Spectroscopic studies of interaction of chlorobenzylidine with DNABiopolymers, 2001
- Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2'-bipyridineJournal of the American Chemical Society, 1989
- Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green teaCarcinogenesis, 1989